Healthy adult males
Conditions
Interventions
Single dose administration of 65 g of the novel chocolate in intervention period
Single dose administration of 65 g of the control chocolate in control period
Sponsors
Meiji Co., Ltd.
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1) All subjects voluntarily signed the informed consent after detailed description and understanding of this study 2) Those who belong to a particular company. 3) Subjects with fasting blood glucose level within normal range between 70 mg/dL and 110 mg/dL using the first blood test.
Exclusion criteria
Exclusion criteria: 1) Those who administer 'Food for Specified Health Use','Foods with Function Clai s' or medicine to have effects on blood glucose metabolism. 2) Patients with diseases undergoing treatments or with medical history of severe diseases that required medication therapy. 3) Those who may suffer from allergy by administering cacao, milk or soybean. 4) Those who were included other clinical trials within one month before giving written informed consent, or during this study. 5) Any other medical and/or health reasons unfavorable to participation in this study, as judged by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood glucose level, the blood glucose areas under the curve (AUC), the maximum (Cmax) blood glucose level | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood insulin level, the blood insulin areas under the curve (AUC), the maximum (Cmax) blood insulin level | — |
Countries
Japan
Contacts
Public ContactTakaya Kitamura
Meiji Co., Ltd. Clinical Study Group
Outcome results
None listed